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Introduction
Development of acute delirium is a serious complication in 
patients hospitalized with acute stroke. Delirium interferes 
with initiation of stroke rehabilitation and causes prolonged 
stay in hospital, worse functional outcome after stroke, and 
increased mortality.1 In 2012, 2 reviews on the occurrence of 
delirium in acute stroke reported incidences in the ranges of 
10% to 48%1 and 2.3% to 66%,2 respectively.
The DSM-V3 is the newest edition of the Diagnostic and 
Statistical Manual of Mental Disorders from the American 
Psychiatric Association. Previous editions also relevant to this 
review include the DSM-IV-TR, the DSM-IV, and the DSM-
III-R.4-6 The definition of delirium is the same in DSM-IV-TR 
and the DSM-IV and differs only slightly from the definition 
in the DSM-V.
The DRS (Delirium Rating Scale) is a 10-item scale made 
to rate the severity of delirium symptoms.7 The original ver-
sion is from 1988 with a later revision in 1998 (the Delirium 
Rating Scale Revised 1998 [DRS-R-98]). The DRS-R-98 
consists of a 13-item symptom severity scale and 3 additional 
diagnostic items.8 Both scales are intended to be completed by 
a clinician using all available information about the patient 
under assessment.
The Confusion Assessment Method (CAM) was developed 
to provide an easy-to-use tool to health staff members not spe-
cifically trained in psychiatry.9 The Confusion Assessment 
Method for the Intensive Care Unit (CAM-ICU) is an edition 
of the CAM designed for use in the intensive care setting.10
In patients with stroke, the diagnosis of delirium is compli-
cated by the fact that acute stroke itself as well as dementia 
caused by previous vascular events may cause delirium-like 
symptoms differing only in time of onset and development. In 
addition, the symptoms and signs of delirium have a fluctuat-
ing course over hours and days. It may therefore be difficult for 
unexperienced observers to correctly identify delirium. Some 
classes of health professionals may also be better equipped than 
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others in the assessment of delirium and this may affect a given 
tool’s ability to identify delirium. Furthermore, it is possible 
that the frequency of assessments will influence the number of 
delirious patients found.
The purpose of this systematic literature review was to exam-
ine whether different assessment methods contribute to the 
variance in delirium incidence. Specifically, the aim was to 
address the influence of (1) choice of assessment tool, (2) fre-
quency of assessment, and (3) type of health professional doing 
the assessment. It was not the purpose of this review to evaluate 
studies directly comparing 2 or more tools with each other.
Methods
A protocol for this review was published online at the 
PROSPERO register (ID CRD42017068360).11 The protocol 
was based on the PRISMA-P guidelines.12 The article has 
been written in accordance with the PRISMA guidelines.13
As described in detail in the systematic review protocol, we 
searched the databases MEDLINE, EMBASE, and PsycINFO. 
A health science librarian was consulted on the search strategy. 
The Medical Subject Headings (MeSH terms) ‘stroke’, ‘cere-
brovascular disorders’, ‘delirium’, ‘confusion’ were searched in 
combination with the words ‘cerebrovascular syndrome’, ‘brain 
ischemia’, ‘brain vascular accident’, ‘cerebrovascular accident’, 
‘confusional state’, ‘psychosyndrome’, ‘brain syndrome’, ‘meta-
bolic encephalopathy’. See review protocol for the exact 
MEDLINE search string.11 The searches at EMBASE and 
PsycINFO were built on the same search words. No date 
restrictions were imposed on any of the searches and all searches 
were finalized in August 2017.
Screening, data extraction, and risk of bias assessments were 
done independently by 2 reviewers ( J.S. and J.V.S.) and consen-
sus established. Disagreement was sought to be resolved through 
discussion between J.S. and J.V.S. If consensus could not be 
reached, a third reviewer (T.C.) resolved the disagreement.
Study designs eligible for the review were prospective and 
retrospective observational cohort studies. Study designs 
excluded from the review were interventional studies, observa-
tional studies other than cohort studies, studies with 3 or less 
patients, and reviews.
To be included, studies had to estimate the delirium inci-
dence, that is, new cases of delirium found during the study 
period, in a population of patients ⩾18 years of age admitted 
with acute stroke as hospital inpatients. Stroke populations 
with any combination of ischaemic stroke, intracerebral haem-
orrhages and subarachnoid haemorrhages were eligible. So 
were populations of patients with symptoms lasting less than 
24 hours if they had relevant acute lesions on cerebral imaging. 
Patients with transient ischaemic attacks without demonstra-
ble acute brain damage on brain imaging were excluded as they 
had full remission of symptoms and constituted a group which 
was treated heterogeneously, for example, in some institutions, 
these patients were admitted to an acute stroke wards and at 
other places they were handled via outpatient clinics. If a study 
encompassed patients both fulfilling and not fulfilling the 
inclusion criteria and the data from the patients fulfilling 
the inclusion criteria could be extracted for separate analysis, 
the study was considered eligible.
A 95% confidence interval (CI) for each study’s delirium 
incidence was calculated. The chi square test of heterogeneity 
was performed and due to significant heterogeneity the 
DerSimonian and Laird Random Effects Model14 was used to 
synthesize the overall delirium incidence estimate. Note that in 
the DerSimonian and Laird Random Effects Model each 
study is given a weight based on the number of patients, but the 
range of weights are compressed as compared with a fixed 
effects model. Data storage, analyses, and figures were done in 
Microsoft Excel and RStudio (©2009-2017 RStudio, Inc, 
Boston, MA, USA).
Results
A total of 3748 unique titles were identified. A total of 134 arti-
cles were read in full length and 30 were included in the 
review.15-44 In these 30 articles, 24 unique populations were 
identified (Figure 1). The discrepancy between the number of 
articles and the number of unique populations was caused by the 
fact that the same population was described in more than one 
article. Thus, 2 populations were described in 2 separate articles 
and 2 populations were reported on in 3 separate articles. The 
included studies were published during the years 1987 to 2017 
and consisted of 2 retrospective and 22 prospective cohort stud-
ies. Table 1 is an overview of the included studies. A total of 21 
studies reported a mean for age which was in the range of 51 to 
79.2 years. The median age (range of 68-74 years) was available 
for those 3 studies which did not report a mean age.
Delirium incidence
The delirium incidence range was 1.4% to 75.6% (see Figure 2). 
Figure 3 shows a graphic representation of the data synthesis for 
the delirium incidence. The chi-square test showed a significant 
heterogeneity across studies (χ2 = 536.5, df = 23, P < 0.0001). 
Cochrane Q = 743.5 (P < .0001) and I2 = 96.9% and the random 
effects model showed a delirium incidence of 22.8%, 95% CI: 
18.2-27.4 (23.9%, 95% CI: 19.5-28.4%, with the 2 retrospective 
studies removed from the model).
Assessment tools
In 16 studies, the tools used were the CAM, CAM-ICU, DRS, 
and DRS-R-98 (exclusively, in combination with each other or 
in combination with DSM criteria). The study by McManus 
et al40 reported 2 delirium incidences for the same population; 
one for the DRS (delirium incidence 26.8%) and one for the 
CAM (delirium incidence 28.1%). Six studies solely used some 
version of the DSM criteria (1 used DSM-V, 3 used DSM-IV 
or DSM-IV-TR, and 2 used DSM-III-R criteria) and 2 studies 
used some other specified criteria for delirium (see Table 1). 
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Looking only at the studies using the CAM, CAM-ICU, DRS, 
and DRS-R-98 (alone or in combinations with each other or 
in combination with DSM criteria), the delirium incidences 
were within a narrower range of 6.6% to 35.3% (Figure 2).
Frequency and timing of assessment tool use
In the prospective studies, delirium assessment was done once 
a day or more in 6 studies. The remaining 16 prospective stud-
ies assessed with a smaller frequency, for example, twice a week. 
The retrospective studies used patient records, either covering 
the entire admission or limited to days 1 through 7.
Marked in green in Table 1 are the 11 prospective studies 
that assessed roughly once a day (eg, daily except Sundays) or 
more often. Looking at the table, comparing these 11 studies 
with those that assessed with a frequency less than roughly 
daily, there is no discernible pattern with respect to delirium 
incidence.
Type of health professional
Information about the type of health professional(s) using a 
specific tool was available from 20 studies (see Table 1). Study 
authors were contacted on 8 occasions to clarify the informa-
tion about which type of health professional had done the 
delirium assessments in their studies. Nine prospective studies 
specifically stated that the persons using the tools had been 
trained to use their specific tool or to apply the delirium 
criteria. No specific pattern as to whether the type of health 
professional doing the assessments had an influence on the 
delirium incidence was discernible.
Quality assessment
A panel of questions was designed to perform a quality assess-
ment of the included studies. The questions were taken from 
Watt et  al45 and were, for some questions, modified slightly. 
Questions on exclusion of aphasic patients, delirium assess-
ment before inclusion into a study, and the timeframes used for 
delirium assessments were added. Table 2 shows the questions 
and the answers for each study in this review. Of the 24 studies, 
5 did not have clearly described characteristics regarding age, 
disease status, and preexisting cognitive impairment. The 
recruitment strategy was nonconsecutive in one population and 
unclear in another three. The inclusion and exclusion criteria 
were judged not to allow for appropriate selection of the respec-
tive studies’ target populations in 2 cases (unclear in 3 cases) 
and aphasic patients were excluded in 9 studies. There were 
missing data on delirium assessments in 11 studies and 2 of 
these did not document reasons for this missing data. The 
delirium assessment was not performed by an independent 
assessor in 8 studies (unclear in an additional 6 studies) but 
only in 2 studies were the delirium assessments not done in a 
standard manner. No studies had an assessment negative for 
delirium before a patient entered the study and only 2 studies 
described the time frame used for a given tool’s application.
Figure 1. Flowchart of the search and article selection process.
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Discussion
In our review, we found a large range in delirium incidences 
from 1.4% to 75.6%. It must be emphasized that none of the 
studies tested a certain screening method against a predefined 
golden standard. The study by Mitasova et  al38 was a study 
comparing blinded assessments between a Czech version of the 
CAM-ICU and the DSM-IV; however, they reported delirium 
incidence for the DSM-IV only and therefore only this was 
included into this review. Based on the data in the included 
studies, we were able to calculate an overall estimate of delir-
ium incidence of approximately 23%.
Even though all populations are acute stroke populations, 
heterogeneity across populations should be assumed. We did 
not do any test for a potential statistically significant difference 
between subgroups (ie, studies using the CAM, DRS, or DRS-
R-98 vs the rest) as the studies were of observational design 
and the heterogeneity was, as mentioned, significant. This 
means that the subgroup pooled estimates and I2 values might 
very well had turned out to be different for other reasons than 
the chosen subgrouping because of unknown confounders and 
any confident conclusions of such tests would therefore be 
impossible to make.
However, the narrower range of incidences from studies 
using the CAM, CAM-ICU, DRS, or DRS-R-98 generates 
the hypothesis that using standardized and validated delirium 
assessment tools such as the CAM, CAM-ICU, DRS, or DRS-
R-98, a more precise detection of acute delirium may be 
obtained in patients with acute stroke. We emphasize that 
results from this review do not allow actual comparison of 
groups of studies with each other due to the heterogeneity of 
the studies. Only one study in this review compared 2 tools 
directly with each other. Further studies comparing delirium 
assessment tools directly with each other are needed.
A study by Infante et al46 was not included into this review, 
because it had patients with transient ischaemic attack 
Figure 2. Figure illustrating the delirium incidences categorized 
according to which assessment tools were used in each of the studies. 
Note that there are 4 studies using solely the CaM, 2 studies found 
incidences of 27.4% and 28.1%, respectively, and are almost 
nondiscernible from each other on the figure. Please note that the study 
by McManus et al is depicted twice, once for the CaM (delirium incidence 
28.1%) and once for the DRS (delirium incidence 26.8%).
abbreviations: CaM, Confusion assessment Method; CaM-iCu, Confusion 
assessment Method for the intensive care unit;RS,, Delirium Rating Scale; 
DRS-R-98, Delirium Rating Scale Revised 1998; DSM, Diagnostic and 
Statistical Manual of Mental Disorders (any edition).
Figure 3. Forest plot. The size of each square visualizes a study’s percentile weight, the horizontal bars indicate the 95% confidence interval (Ci), the 
centre of the diamond indicates the overall delirium incidence estimate, and the width of the diamond represents the 95% Ci of the overall estimate.
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(symptoms lasting less than 24 hours and no acute cerebral 
lesions demonstrated on imaging) intermixed in its population 
but is still worth mentioning. The study found a delirium inci-
dence of 52% when using the 4AT instrument but a lower inci-
dence of 32% when the DSM-V criteria were applied to the 
same patients by the same neurologist. The 4AT was available 
for the first time in 2011 and is designed as an instrument for 
rapid delirium screening.47
Concerning the types of health professionals using the tools 
and the delirium incidence found, no discernible pattern was 
evident from our review. As mentioned above, the heterogene-
ity among the studies was considerable and no subgroup analy-
ses were therefore done. To our knowledge, no previous studies 
have specifically addressed the possible influence of the type of 
health professional on the detection rate of delirium. Yet, this 
question must remain unanswered.
Due to the fluctuating symptoms of delirium, it could be 
speculated that the frequency of assessments will have an 
impact on the detection rate of delirium. However, due to the 
multitude of different tools in use across these 22 prospective 
studies, no firm conclusions can be made for any of the tools as 
to whether there is a correlation between the frequency and 
delirium detection.
Several sources for bias may exist. An important bias is the 
fact that the studies had clearly different types of settings and 
spanned a rather wide range of publication years. For example, 
some were conducted in modern stroke wards, others in neuro-
logical semi-intensive care units and others again in older set-
tings. The types of stroke also differed across studies. Some 
reported both on ischaemic and haemorrhagic strokes, others 
only one type. The underlying stroke etiology itself might also 
in some situations contribute to the development of delirium. 
Another potential bias may come in- or exclusion of aphasic 
patients. The exclusion of aphasic patients may result in a lower 
incidence of delirium. Thought content and attention may be 
harder to judge when language is impaired, and this makes 
severely aphasic patients more difficult to assess for delirium. A 
validated tool for assessing severely aphasic patients is obviously 
needed. The CAM-ICU10 does not require the patient to speak 
but severe aphasia might still interfere with patient’s ability to 
understand what is being said without confusion being present. 
In addition, perceptual deficits other than aphasia might also 
make a delirium assessment difficult. Data on perceptual defi-
cits other than aphasia were not collected in this review.
Assessment for delirium before the patients entered a given 
study was not done in any of the included studies. It is quite 
conceivable that some patients might have been delirious 
before inclusion (and before admission or before their stroke). 
Another bias might come from the time frames used when 
evaluating patients for the presence of delirium. For a given 
tool, some studies might consistently have used longer time 
frames (eg, looking back 24 hours instead of 8 hours) than 
others. The effect this might have on the incidence of delirium 
is unknown.
Conclusions
Delirium is a common complication in acute stroke. The wide 
ranges of delirium incidence reported in the different stroke 
studies imply that delirium can be difficult to recognize in 
patients with stroke, leading to both under- and overdiagnosis.
No firm conclusions about a possible correlation of choice 
of tool, assessment frequency, and delirium incidence could be 
made due to the great heterogeneity of the study populations. 
Only 1 study compared 2 tools directly with each other. Further 
studies comparing delirium assessment tools directly with each 
other are needed.
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